Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Leaf

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Urology|July 1, 1997
The effects of (L)-2-oxothiazolidine-4-carboxylate on urinary oxalate excretionR P Holmes, D G Assimos, C D Leaf, et al.
Journal of Occupational and Environmental Medicine|May 1, 1995
An expert system based preventive medicine examination adviserP Harber, K Czisny, P Hsu, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1983
Comparison of distribution beyond coronary stenoses of blood and asanguineous cardioplegic solutionsJ M Robertson, G D Buckberg, J Vinten-Johansen, et al.
Carcinogenesis|June 1, 1987
Influence of ascorbic acid dose on N-nitrosoproline formation in humansC D Leaf, A J Vecchio, D A Roe, et al.
IARC Scientific Publications|January 1, 1987
Relationship between ascorbic acid dose and N-nitrosoproline excretion in humans on controlled dietsC D Leaf, A J Vecchio, D A Roe, et al.
Carcinogenesis|March 1, 1989
Nitrosation by stimulated macrophages. Inhibitors, enhancers and substratesH Kosaka, J S Wishnok, M Miwa, et al.
Biochemistry|November 29, 1988
Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediateM A Marletta, P S Yoon, R Iyengar, et al.
Journal of Clinical Pharmacology|November 10, 1998
Pharmacokinetics of 2-oxothiazolidine-4-carboxylate, a cysteine prodrug, and cysteineP R Gwilt, L E Radick, X Y Li, et al.
Environmental Health Perspectives|March 1, 1993
Urinary markers for exposures to alkylating or nitrosating agentsJ S Wishnok, S R Tannenbaum, W G Stillwell, et al.
American Journal of Respiratory and Critical Care Medicine|October 14, 1998
L-2-Oxothiazolidine-4-carboxylic acid prevents endotoxin-induced cardiac dysfunctionB Y Poon, C M Goddard, C D Leaf, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Urology|July 1, 1997
The effects of (L)-2-oxothiazolidine-4-carboxylate on urinary oxalate excretionR P Holmes, D G Assimos, C D Leaf, et al.
Journal of Occupational and Environmental Medicine|May 1, 1995
An expert system based preventive medicine examination adviserP Harber, K Czisny, P Hsu, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 1983
Comparison of distribution beyond coronary stenoses of blood and asanguineous cardioplegic solutionsJ M Robertson, G D Buckberg, J Vinten-Johansen, et al.
Carcinogenesis|June 1, 1987
Influence of ascorbic acid dose on N-nitrosoproline formation in humansC D Leaf, A J Vecchio, D A Roe, et al.
IARC Scientific Publications|January 1, 1987
Relationship between ascorbic acid dose and N-nitrosoproline excretion in humans on controlled dietsC D Leaf, A J Vecchio, D A Roe, et al.
Carcinogenesis|March 1, 1989
Nitrosation by stimulated macrophages. Inhibitors, enhancers and substratesH Kosaka, J S Wishnok, M Miwa, et al.
Biochemistry|November 29, 1988
Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediateM A Marletta, P S Yoon, R Iyengar, et al.
Journal of Clinical Pharmacology|November 10, 1998
Pharmacokinetics of 2-oxothiazolidine-4-carboxylate, a cysteine prodrug, and cysteineP R Gwilt, L E Radick, X Y Li, et al.
Environmental Health Perspectives|March 1, 1993
Urinary markers for exposures to alkylating or nitrosating agentsJ S Wishnok, S R Tannenbaum, W G Stillwell, et al.
American Journal of Respiratory and Critical Care Medicine|October 14, 1998
L-2-Oxothiazolidine-4-carboxylic acid prevents endotoxin-induced cardiac dysfunctionB Y Poon, C M Goddard, C D Leaf, et al.
Pageof 3